Advertisement

PharmacoEconomics & Outcomes News

, Volume 825, Issue 1, pp 15–15 | Cite as

Determining optimal use of an HIV vaccine in South Africa

Clinical study
  • 5 Downloads

Reference

  1. Selinger C, et al. Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa. Vaccine : 16 Mar 2019. Available from: URL: http://doi.org/10.1016/j.vaccine.2019.02.073

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations